Table 1.
Clinical Characteristics of the Study Sample by Hepatic Steatosis Status
Clinical Characteristics* | Hepatic Steatosis (n = 479) | No Hepatic Steatosis (n = 2,294) | Overall (N = 2,773) |
---|---|---|---|
Age (years) | 52 ± 11 | 51 ± 10 | 51 ± 11 |
Women, n (%) | 266 (55.5%) | 1,077 (46.9%) | 1,343 (48.9%) |
Third Generation cohort, n (%) | 274 (57.2%) | 1,421 (61.9%) | 1,695 (61.1%) |
Current smoking, n (%) | 51 (10.6%) | 257 (11.2%) | 308 (11.1%) |
BMI (kg/m2) | 28.7 (0.17) | 26.5 (0.16) | 26.4 (0.19) |
Ideal (<25 kg/m2) | 49 (10.2%) | 916 (39.9%) | 965 (34.8%) |
Intermediate (25 to <30 kg/m2) | 169 (35.3%) | 931 (40.6%) | 1,100 (39.7%) |
Poor (≥30 kg/m2) | 261 (54.5%) | 447 (19.5%) | 708 (25.5%) |
PAI | |||
Ideal (PAI ≥75th percentile) | 111 (23.2%) | 599 (26.1%) | 710 (25.6%) |
Intermediate (PAI 25th‐74th percentile) | 236 (49.3%) | 1,145 (49.9%) | 1,381 (49.8%) |
Poor (PAI <25th percentile) | 132 (27.6%) | 550 (24.0%) | 682 (24.6%) |
Total cholesterol | |||
Ideal (<200 mg/dL without treatment) | 257 (53.7%) | 1,344 (58.6%) | 1,601 (57.7%) |
Intermediate (200‐239 mg/dL or treated) | 161 (33.6%) | 726 (31.6%) | 887 (35.0%) |
Poor (≥240 mg/dL) | 61 (12.7%) | 224 (9.8%) | 285 (10.3%) |
Blood pressure | |||
Ideal (SBP <120 mm Hg and DBP <80 mm Hg without treatment) | 118 (24.6%) | 1,128 (49.2%) | 1,246 (44.9%) |
Intermediate (SBP 120‐139 mm Hg, DBP 80‐89 mm Hg, or treated) | 328 (68.5%) | 1,077 (46.9%) | 1,405 (50.7%) |
Poor (SBP ≥140 mm Hg or DBP ≥90 mm Hg) | 33 (6.9%) | 89 (3.9%) | 122 (4.4%) |
Blood sugar | |||
Ideal (<100 mg/dL without treatment) | 216 (45.1%) | 1,678 (73.1%) | 1,894 (68.3%) |
Intermediate (100‐125 mg/dL or treated) | 75 (3.3%) | 541 (23.6%) | 755 (27.2%) |
Poor (≥126 mg/dL) | 49 (10.2%) | 75 (3.3%) | 124 (4.5%) |
AHA Life’s Simple 7 | 2 ± 1 | 3 ± 1 | 3 ± 1 |
Clinical characteristics are represented as mean ± SD or n (%).
Abbreviations: AHA, American Heart Association; BMI, body mass index; DBP, diastolic blood pressure; PAI, physical activity index; SBP, systolic blood pressure.